Financial Year |
March 31 2023 |
Monetary Funds |
548,102,286.98 |
Held-for-trading Financial Assets |
10,500,000.00 |
Notes Receivable |
21,033,096.93 |
Accounts Receivable |
84,951,418.77 |
Advances to Suppliers |
9,690,317.83 |
Other Receivables |
1,241,293.48 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
99,947,943.11 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
11,830,278.43 |
Total Current Assets |
802,091,428.88 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
108,070,198.86 |
Long-term Equity Investment |
459,937,430.15 |
Investment Properties |
104,718,103.28 |
Fixed Assetes |
325,942,207.21 |
Under-construction Projects |
3,845,000.57 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
25,122,319.57 |
R&D expenses |
-- |
Goodwill |
59,132,206.39 |
Long-Term Deferred and Prepaid Expenses |
225,265.74 |
Deferred Income Tax Assets |
8,238,801.91 |
Other Non-Current Assets |
3,900.00 |
Sub-Total of Non-Current Assets |
1,347,776,509.70 |
Total Assets |
2,149,867,938.58 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
57,295,062.00 |
Accounts Payable |
63,661,507.36 |
Accounts Received In Advance |
331,962.29 |
Employee Compensation Payable |
8,890,350.18 |
Taxes Payable |
5,251,320.59 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
4,432,559.79 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
393,187.98 |
Other Current Liabilities |
325,339.35 |
Sub-Total of Current Liabilities |
145,124,789.20 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
19,671,861.78 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
33,972,130.44 |
Total Liabilities |
179,096,919.64 |
Paid-In Capital(Or Share Stock) |
176,762,528.00 |
Capital Surplus |
698,400,746.44 |
Surplus Reserve |
137,487,869.58 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
799,548,006.18 |
Minority Stockholder's Interest |
5,169,159.95 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,965,601,858.99 |
Owner's Equity(Stockholder's Equity) |
1,970,771,018.94 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
2,149,867,938.58 |